Adult Soft Tissue Sarcoma: Clinical Trials

8 trials for Adult Soft Tissue Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 withdrawn, 1 active not recruiting, 1 unknown. 2 Not applicable, 2 Phase 1, 2 Phase 2, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Unknown 1, Withdrawn 1
Phase 12Completed 2
Phase 22Completed 1, Withdrawn 1
Phase 32Active not recruiting 1, Completed 1
Early Phase 11Completed 1

Follow Adult Soft Tissue Sarcoma: new trials by email Literature Review of Adult Soft Tissue Sarcoma trials Research Report on Adult Soft Tissue Sarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
Ezabenlimab + BI907828 - Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer
Phase 2WithdrawnInstitut BergoniƩ2024-06-142025-09-02
Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma
Neoadjuvant RT, Pre-radiotherapy mpMRI, Post-radiotherapy mpMRI - Soft Tissue Sarcoma, Adult Soft Tissue Sarcoma
Not applicableUnknownCentre Leon Berard252023-04-212023-10-30
Preoperative vs Postoperative IMRT for Extremity/Truncal STS
Preoperative intensity modulated radiation therapy, Postoperative intensity modulated radiation therapy - Adult Soft Tissue Sarcoma
Phase 3Active not recruitingMount Sinai Hospital, Canada2102016-06-012024-02-20
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall
NBTXR3, Radiation therapy - Adult Soft Tissue Sarcoma
Phase 2 / Phase 3CompletedNanobiotix1802015-03-032021-04-06
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
Real-Time CEUS, SWE, Definity Suspension for Injection - Adult Soft Tissue Sarcoma, Bone Sarcoma
Early Phase 1CompletedUniversity of Southern California252014-12-242024-01-23
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity
NBTXR3 - Adult Soft Tissue Sarcoma
Phase 1CompletedNanobiotix222011-10-012020-10-06
Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal Sarcoma
Proton Beam Radiation Therapy - Adult Soft Tissue Sarcoma
Not applicableWithdrawnAbramson Cancer Center at Penn Medicine2009-11-012021-06-10
Vaccine Therapy in Treating Patients With Metastatic Cancer
interleukin-2, MAGE-12 peptide vaccine, Montanide ISA-51 - Lung Cancer, Adult Soft Tissue Sarcoma
Phase 1CompletedNational Cancer Institute (NCI)2000-07-012024-03-04

Narrower conditions

Sarcoma (8)  ·  Bone Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Colorectal Neoplasms (2)  ·  Neoplasms (2)  ·  Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Colonic Neoplasms (1)  ·  Eye Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Genetic Diseases, Inborn (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)

Broader conditions

Neoplasms by Histologic Type (8)  ·  Neoplasms, Connective and Soft Tissue (8)  ·  Neoplasms (6)  ·  Neoplasms by Site (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Bone Diseases (2)  ·  Breast Diseases (2)  ·  Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Disease Attributes (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)

Interventions

Injections (1)  ·  Interleukin-2 (1)  ·  Proton Therapy (1)  ·  Radiotherapy (1)  ·  Transurethral Resection of Bladder (1)  ·  brigimadlin (1)  ·  montanide ISA 51 (1)

Sponsors

Nanobiotix (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Centre Leon Berard (1)  ·  Institut BergoniĆ© (1)  ·  Mount Sinai Hospital, Canada (1)  ·  National Cancer Institute (NCI) (1)  ·  University of Southern California (1)

Countries

France (4)  ·  United States (4)  ·  Belgium (2)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Italy (1)  ·  Norway (1)  ·  Philippines (1)  ·  Poland (1)  ·  Romania (1)  ·  South Africa (1)  ·  Spain (1)

Top investigators

Curtiland Deville, MD (1)  ·  Francesco M. Marincola (1)  ·  Mittul Gulati (1)  ·  Peter Chung, MD (1)  ·  Peter Ferguson, MD, FRCSC (1)

Results publications

PMID 31296491

NIH funding

2023 (1), P30CA014089 (1)